ACH
SYNH

ArrowMark Colorado Holdings’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

ArrowMark Colorado Holdings’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,228,217
Closed -$51.8M – 332
2023
Q2 		$51.8M Buy
1,228,217
+1,093,217
+810% +$44.2M 0.57% 57
2023
Q1 		$4.81M Buy
+135,000
New +$4.9M 0.05% 202
2022
Q4 		– Sell
-1,164,899
Closed -$54.9M – 332
2022
Q3 		$54.9M Sell
1,164,899
-23,519
-2% -$1.52M 0.67% 50
2022
Q2 		$85.2M Sell
1,188,418
-388,156
-25% -$28.4M 0.97% 28
2022
Q1 		$128M Sell
1,576,574
-16,489
-1% -$1.39M 1.12% 26
2021
Q4 		$164M Sell
1,593,063
-400,333
-20% -$38.4M 1.31% 17
2021
Q3 		$174M Sell
1,993,396
-11,540
-0.6% -$1.04M 1.36% 15
2021
Q2 		$179M Sell
2,004,936
-153,826
-7% -$13M 1.35% 17
2021
Q1 		$164M Sell
2,158,762
-363,115
-14% -$27.4M 1.22% 21
2020
Q4 		$172M Buy
2,521,877
+137,540
+6% +$8.57M 1.33% 17
2020
Q3 		$127M Sell
2,384,337
-57,478
-2% -$3.42M 1.21% 26
2020
Q2 		$142M Buy
2,441,815
+24,549
+1% +$1.32M 1.47% 22
2020
Q1 		$95.3M Buy
2,417,266
+105,551
+5% +$6.17M 1.25% 26
2019
Q4 		$137M Buy
2,311,715
+120,024
+5% +$6.45M 1.22% 23
2019
Q3 		$117M Sell
2,191,691
-828,129
-27% -$42.5M 1.16% 31
2019
Q2 		$154M Buy
3,019,820
+678,084
+29% +$31.6M 1.48% 13
2019
Q1 		$121M Sell
2,341,736
-426,157
-15% -$20.7M 1.14% 25
2018
Q4 		$109M Buy
2,767,893
+62,385
+2% +$2.9M 1.14% 24
2018
Q3 		$139M Buy
2,705,508
+169,288
+7% +$8.29M 1.17% 23
2018
Q2 		$119M Buy
2,536,220
+87,505
+4% +$3.62M 1.09% 24
2018
Q1 		$86.9M Sell
2,448,715
-3,871
-0.2% -$152K 0.87% 37
2017
Q4 		$107M Buy
2,452,586
+553,208
+29% +$25.8M 1.08% 28
2017
Q3 		$99.3M Buy
1,899,378
+52,636
+3% +$2.94M 1.13% 25
2017
Q2 		$108M Sell
1,846,742
-1,148,519
-38% -$59.7M 1.34% 17
2017
Q1 		$137M Buy
2,995,261
+643,845
+27% +$32M 1.87% 7
2016
Q4 		$124M Buy
2,351,416
+426,482
+22% +$20.6M 1.95% 6
2016
Q3 		$85.8M Buy
1,924,934
+189,163
+11% +$8.2M 1.56% 14
2016
Q2 		$66.2M Buy
+1,735,771
New +$76.3M 1.34% 20

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ArrowMark Colorado Holdings's SYNH Position: Q3 2023 in Review

ArrowMark Colorado Holdings sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,228,217 shares — an estimated $51.8M sold.

ArrowMark Colorado Holdings first reported a position in SYNH in Q2 2016 and held it in 28 quarters. The position peaked at $179M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • ArrowMark Colorado Holdings reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 1,228,217 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $51.8M.
  • ArrowMark Colorado Holdings first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 28 quarters.
  • ArrowMark Colorado Holdings's Syneos Health, Inc. Class A Common Stock position peaked at $179M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.